US2015099797A1PendingUtilityA1

Oligonucleotide compositions with enhanced efficiency

Assignee: LIFE TECHNOLOGIES CORPPriority: Feb 1, 2002Filed: Dec 16, 2014Published: Apr 9, 2015
Est. expiryFeb 1, 2022(expired)· nominal 20-yr term from priority
A61P 37/02A61P 9/00A61P 43/00A61P 27/02A61P 31/12A61P 31/18A61P 29/00A61P 35/00A61P 31/20A61P 1/04A61P 17/06C12N 2310/315C12N 2320/31C12Y 301/03048C12N 2320/50C12N 15/1137C12N 15/113A61K 31/713C12N 2310/111C12N 2330/30C12N 15/111C12N 15/1135C12N 2310/11C12Y 207/11022C12N 2310/14C12N 2320/30C12N 2320/11
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The oligonucleotide compositions of the present invention make use of combinations of oligonucleotides. In one aspect, the invention features an oligonucleotide composition including at least 2 different oligonucleotides targeted to a target gene. This invention also provides methods of inhibiting protein synthesis in a cell and methods of identifying oligonucleotide compositions that inhibit synthesis of a protein in a cell.

Claims

exact text as granted — not AI-modified
1 - 29 . (canceled) 
     
     
         30 . An oligonucleotide composition comprising at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene. 
     
     
         31 . A method of inhibiting protein synthesis in a cell comprising contacting the cell with at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene. 
     
     
         32 . A method of identifying function of a gene encoding a protein comprising: contacting the cell with at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene and assaying for a change in a detectable phenotype in the cell resulting from the inhibition of protein expression, to thereby determine the function of a gene. 
     
     
         33 . A method of making an oligonucleotide composition comprising: combining at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene wherein, the individual oligonucleotides are not separately tested for their ability to inhibit protein synthesis prior to their incorporation into the composition.

Join the waitlist — get patent alerts

Track US2015099797A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.